Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 255Rectal Neoplasms 155Colonic Neoplasms 128Stomach Neoplasms 100Pancreatic Neoplasms 94Breast Neoplasms 77Esophageal Neoplasms 76Neoplasm Metastasis 58Squamous Cell Carcinoma of Head and Neck 56Head and Neck Neoplasms 56Neoplasms 43Adenocarcinoma Of Esophagus 37Esophageal Squamous Cell Carcinoma 27Adenocarcinoma 25Unspecified Adult Solid Tumor, Protocol Specific 15Carcinoma, Hepatocellular 15Parkinson Disease 4, Autosomal Dominant Lewy Body 13Anus Neoplasms 12Keratosis, Actinic 11Gastrointestinal Neoplasms 11Biliary Tract Neoplasms 11Gallbladder Neoplasms 10Carcinoma, Squamous Cell 10Urinary Bladder Neoplasms 9Nasopharyngeal Carcinoma 9Liver Neoplasms 9Cholangiocarcinoma 9Carcinoma 9Bile Duct Neoplasms 9Recurrence 8

Interventions

toripalimab 1titanium silicide 1Nivolumab 1Gemcitabine 1Folfox protocol 1Fluorouracil 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Biliary Tract Cancer × Fluorouracil × Clear all
NCT04217954 2023-06-23

HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC

Peking University

Phase 2 Completed
32 enrolled
Gastrointestinal

Advanced Biliary Tract Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡